Triptans and CGRP blockade - impact on the cranial vasculature.
about
Side effects associated with current and prospective antimigraine pharmacotherapies.PACAP38 in human models of primary headaches.Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrinsDrosophila CaV2 channels harboring human migraine mutations cause synapse hyperexcitability that can be suppressed by inhibition of a Ca2+ store release pathway
P2860
Triptans and CGRP blockade - impact on the cranial vasculature.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Triptans and CGRP blockade - impact on the cranial vasculature.
@en
Triptans and CGRP blockade - impact on the cranial vasculature.
@nl
type
label
Triptans and CGRP blockade - impact on the cranial vasculature.
@en
Triptans and CGRP blockade - impact on the cranial vasculature.
@nl
prefLabel
Triptans and CGRP blockade - impact on the cranial vasculature.
@en
Triptans and CGRP blockade - impact on the cranial vasculature.
@nl
P2093
P2860
P50
P921
P1476
Triptans and CGRP blockade - impact on the cranial vasculature.
@en
P2093
Alejandro Labastida-Ramírez
Christian Lampl
Francesca Cortese
Francesca Marchese
Lanfranco Pellesi
School of Advanced Studies of the European Headache Federation (EHF-SAS)
P2860
P2888
P356
10.1186/S10194-017-0811-5
P5008
P577
2017-10-10T00:00:00Z
P6179
1092156059